Genea Group Media Releases October 2020

October 2020

Australian fertility clinic delivers more hope by reducing cost uncertainty

Posted: 24/10/2020 8:00:00 AM

In an Australian first Genea Fertility is bringing some comfort to patients when it comes to concerns about the financial impact of IVF, making a promise to do an additional two cycles at no out of pocket cost, if more than three stimulated cycles are required^*.

Position Statement

Posted: 10/10/2020 12:44:44 PM

Genea's Scientific Director Steven McArthur on non-invasive Pre-implantation Genetic Screening.

Media Contact

Alice Ross
M: 0421 741 737
E: alice.ross@genea.com.au

About Genea

Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 31 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. In September 2017, Genea was listed in the Australian Financial Review’s Top 50 Most Innovative Companies List, ranking number 25.

Our response to Novel Coronavirus (COVID-19)

For all enquiries, call:
1300 361 795

Email us

Genea shares patient stories to help people experiencing infertility to understand that they are not alone. Hearing about other people experiencing the same challenges is a powerful way to break the isolation and stigma that often surrounds infertility. We share these stories with the intent to inform, educate and comfort and have no intention to create unreasonable expectations of beneficial treatment. Similarly, we have no intention for our community to believe the stories told are the outcomes that would be achieved for every patient. Read more about our policy on sharing personal stories.

Home Privacy Policy Disclaimer Genea Group